Skip to content
healthcare.dev

Abiraterone Acetate

NDC 42291-024, Abiraterone, tablet, from AvKARE.

Product NDC
42291-024
Status
Listed
Labeler
AvKARE
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208327
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42291-024 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABIRATERONE ACETATE250 mg/1

Pharmacologic classes

Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

Package NDCNDC-11Package
42291-024-1242291002412120 TABLET in 1 BOTTLE (42291-024-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7f82d549-6654-1efd-e053-2991aa0aa28d

Use it

Look up 42291-024 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42291-024 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42291-024. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.